Increased  	Increased  	 VBN	O
hip  	hip  	 JJ	O
fracture  	fracture  	 NN	B-NP
and  	and  	 CC	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
chronic  	chronic  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
disease  	disease  	 NN	I-NP
individuals 	individuals 	 NNS	I-NP
:  	:  	 :	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
competing  	competing  	 VBG	B-NP
risks  	risks  	 NNS	I-NP
Many  	Many  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
shown  	shown  	 VBN	O
a  	a  	 DT	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
chronic  	chronic  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
CKD 	CKD 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
fracture 	fracture 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
increased  	increased  	 VBN	B-NP
mortality  	mortality  	 NN	I-NP
in  	in  	 IN	O
CKD  	CKD  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
competing  	competing  	 JJ	O
risk  	risk  	 NN	B-NP
scenario  	scenario  	 NN	I-NP
not  	not  	 RB	O
accounted  	accounted  	 VBN	O
for  	for  	 IN	O
in  	in  	 IN	O
previous  	previous  	 JJ	O
studies 	studies 	 NNS	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
aim  	aim  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
true  	true  	 JJ	O
impact  	impact  	 NN	O
of  	of  	 IN	O
CKD  	CKD  	 NNP	B-NP
on  	on  	 IN	O
hip  	hip  	 JJ	O
fracture  	fracture  	 NN	B-NP
after  	after  	 IN	O
accounting  	accounting  	 NN	O
for  	for  	 IN	O
a  	a  	 DT	O
competing  	competing  	 JJ	O
risk  	risk  	 NN	O
with  	with  	 IN	O
death 	death 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
conducted  	conducted  	 VBD	O
a  	a  	 DT	O
population-based  	population-based  	 JJ	B-NP
cohort  	cohort  	 JJ	I-NP
study  	study  	 NN	I-NP
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
impact  	impact  	 NN	O
of  	of  	 IN	O
CKD  	CKD  	 NNP	B-NP
on  	on  	 IN	O
hip  	hip  	 JJ	O
fractures  	fractures  	 NN	O
in  	in  	 IN	O
individuals  	individuals  	 NNS	O
aged  	aged  	 VBN	O
≥50years  	≥50years  	 CD	O
old  	old  	 JJ	O
registered  	registered  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
SIDIAP 	SIDIAP 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
Q 	Q 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
database  	database  	 NN	I-NP
( 	( 	 -LRB-	O
representative  	representative  	 NN	B-NP
of  	of  	 IN	O
1.9  	1.9  	 CD	O
million  	million  	 CD	O
people  	people  	 NNS	O
in  	in  	 IN	O
Catalonia 	Catalonia 	 NNP	B-NP
,  	,  	 ,	O
Spain 	Spain 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Cox  	Cox  	 NNP	B-NP
regression  	regression  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
estimate  	estimate  	 VB	O
hazard  	hazard  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
death  	death  	 NN	O
and  	and  	 CC	O
hip  	hip  	 JJ	O
fracture  	fracture  	 NN	B-NP
according  	according  	 VBG	O
to  	to  	 TO	O
CKD  	CKD  	 NNP	B-NP
status 	status 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
competing  	competing  	 JJ	O
risk  	risk  	 NN	O
( 	( 	 -LRB-	O
Fine  	Fine  	 NNP	O
and  	and  	 CC	O
Gray 	Gray 	 NNP	O
)  	)  	 -RRB-	O
model  	model  	 NN	O
was  	was  	 VBD	O
fitted  	fitted  	 VBN	O
to  	to  	 TO	O
estimate  	estimate  	 VB	O
sub-HR  	sub-HR  	 JJ	B-NP
for  	for  	 IN	O
hip  	hip  	 JJ	O
fracture  	fracture  	 NN	B-NP
in  	in  	 IN	O
CKD  	CKD  	 NNP	B-NP
or  	or  	 CC	O
CKD-free  	CKD-free  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
accounting  	accounting  	 NN	O
for  	for  	 IN	O
differential  	differential  	 JJ	B-NP
mortality 	mortality 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
873,073  	873,073  	 NNP	O
( 	( 	 -LRB-	O
32,934  	32,934  	 NNP	O
( 	( 	 -LRB-	O
3.8 	3.8 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
CKD 	CKD 	 NNP	B-NP
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
3  	3  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
During  	During  	 IN	O
follow-up 	follow-up 	 NNP	O
,  	,  	 ,	O
4,823  	4,823  	 NNP	O
( 	( 	 -LRB-	O
14.6 	14.6 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
CKD  	CKD  	 NNP	B-NP
and  	and  	 CC	O
36,328  	36,328  	 NNP	O
( 	( 	 -LRB-	O
4.3 	4.3 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
CKD-free  	CKD-free  	 JJ	B-NP
participants  	participants  	 NNS	I-NP
died  	died  	 VBD	O
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
,  	,  	 ,	O
1.83  	1.83  	 CD	O
[ 	[ 	 -LRB-	O
95 	95 	 CD	O
%  	%  	 NN	O
CI 	CI 	 NNP	O
,  	,  	 ,	O
1.78-1.89 	1.78-1.89 	 CD	O
] 	] 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
whilst  	whilst  	 CD	B-NP
522  	522  	 CD	O
( 	( 	 -LRB-	O
1.59 	1.59 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
6,292  	6,292  	 NNP	O
( 	( 	 -LRB-	O
0.75 	0.75 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
sustained  	sustained  	 VBD	O
hip  	hip  	 JJ	O
fractures 	fractures 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Adjusted  	Adjusted  	 NNP	B-NP
Cox  	Cox  	 NNP	I-NP
models  	models  	 NNS	I-NP
showed  	showed  	 VBD	O
a  	a  	 DT	O
significantly  	significantly  	 RB	O
increased  	increased  	 VBN	B-NP
risk  	risk  	 NN	I-NP
of  	of  	 IN	O
hip  	hip  	 JJ	O
fractures  	fractures  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
CKD  	CKD  	 NNP	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
,  	,  	 ,	O
1.16  	1.16  	 CD	O
[ 	[ 	 -LRB-	O
1.06-1.27 	1.06-1.27 	 NNP	O
] 	] 	 -RRB-	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
this  	this  	 DT	O
association  	association  	 NN	O
was  	was  	 VBD	O
attenuated  	attenuated  	 VBN	O
in  	in  	 IN	O
competing  	competing  	 VBG	B-NP
risk  	risk  	 NN	I-NP
models  	models  	 NNS	I-NP
accounting  	accounting  	 NN	O
for  	for  	 IN	O
mortality  	mortality  	 NN	O
( 	( 	 -LRB-	O
SHR 	SHR 	 NNP	B-NP
,  	,  	 ,	O
1.14  	1.14  	 CD	O
[ 	[ 	 -LRB-	O
1.03-1.27 	1.03-1.27 	 NNP	O
] 	] 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Both  	Both  	 DT	O
death  	death  	 NN	O
and  	and  	 CC	O
hip  	hip  	 JJ	O
fracture  	fracture  	 NN	B-NP
rates  	rates  	 NNS	I-NP
are  	are  	 VBP	O
increased  	increased  	 VBN	O
( 	( 	 -LRB-	O
by  	by  	 IN	O
83 	83 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
16 	16 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
CKD  	CKD  	 NNP	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
CKD  	CKD  	 NNP	B-NP
and  	and  	 CC	O
hip  	hip  	 JJ	O
fractures  	fractures  	 NN	O
is  	is  	 VBZ	O
attenuated  	attenuated  	 VBN	O
when  	when  	 WRB	O
an  	an  	 DT	O
excess  	excess  	 NN	O
of  	of  	 IN	O
mortality  	mortality  	 NN	O
is  	is  	 VBZ	O
taken  	taken  	 VBN	O
into  	into  	 IN	O
account 	account 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
competing  	competing  	 JJ	O
risk  	risk  	 NN	O
with  	with  	 IN	O
death  	death  	 NN	O
must  	must  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
in  	in  	 IN	O
future  	future  	 JJ	O
analyses  	analyses  	 NNS	O
of  	of  	 IN	O
association  	association  	 NN	O
between  	between  	 IN	O
CKD  	CKD  	 NNP	B-NP
and  	and  	 CC	O
any  	any  	 DT	O
health  	health  	 NN	B-NP
outcomes 	outcomes 	 NNS	I-NP
.  	.  	 .	O
